Dietary Lipid Quantity and Quality Modulate the Postprandial Metabolomic Profile in Patients with Metabolic Syndrome
Nutrients · 2024
DOI: 10.3390/nu16244267 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Nutrients, 2024. Verfasst von Marina Mora-Ortiz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, 14004 Cordoba, Spain. Hauptthemen laut MEDLINE: Dietary Fats, Metabolic Syndrome, Metabolomics, Postprandial Period. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU 6th Framework Program Integrated Project, LIPGENE—an EU 6th Framework Program Integrated Project, Ministry of Economy and Competitiveness.
Abstract (Originalsprache)
The literature on the postprandial metabolic changes in individuals with Metabolic Syndrome (MetS) remains limited, despite the fact that postprandial states represent the most common physiological condition in Western societies. Background/Objectives: The objective of this study was to investigate the plasma metabolomics profile in both fasting and postprandial states following a high-fat challenge in individuals with MetS who consumed diets with varying quantities and qualities of dietary fat over 12 weeks.
Methods
Seventy-five patients with MetS (28 males and 47 females) from the Spanish LIPGENE cohort were included in the study. MetS patients were randomly stratified to follow one of four dietary interventions (isoenergetic diets) for a 12-week long-term study. The four diets were high in saturated fatty acids and high in monounsaturated fatty acids (HSFA and HMUFA), low-fat high-complex carbohydrates (LFHCC), and LFHCC supplemented with n-3. The metabolomics analysis of plasma samples was carried out using Liquid Chromatography Time-of-Flight Mass Spectrometry (LC-TOF/MS).
Results
We observed a decrease in inflammation biomarkers, including acetylcarnitine and L-carnitine during the fasting state and hexanoyl-L-carnitine and isobutyryl-L-carnitine during the postprandial period, mediated by the replacement of HSFA with HMUFA. Additionally, antioxidant compounds such as 4-hydroxybenzaldehyde and L-valine were expressed at higher levels after consumption of the HMUFA diet compared to the HSFA diet. HSFA also presented altered levels of phosphatidylcholine, a metabolite previously linked with insulin resistance.
Conclusions
These findings suggest that replacing HSFA with HMUFA may reduce inflammation and improve antioxidant profiles, supporting the potential for tailored dietary interventions in individuals with MetS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, 14004 Cordoba, Spain.
- Maimonides Biomedical Research Institute of Cordoba (IMIBIC), 14004 Cordoba, Spain.
- Department of Medical and Surgical Sciences, Universidad de Córdoba, 14071 Cordoba, Spain.
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Department of Food and Health, Instituto de la Grasa, Spanish National Research Council (CSIC), 28006 Seville, Spain.
- Departamento de Química Analítica y Nanoquímica, Edificio Marie Curie (anexo), Universidad de Córdoba, 14071 Cordoba, Spain.
ORCID-Profile: Marina Mora-Ortiz, Feliciano Priego-Capote, Francisco M Gutierrez-Mariscal, Juan F Alcala-Diaz, Javier Delgado-Lista, Pablo Perez-Martinez, Helen M Roche, José López-Miranda
Förderung
- EU 6th Framework Program Integrated Project
- LIPGENE—an EU 6th Framework Program Integrated Project
- Ministry of Economy and Competitiveness
- Carlos III Institute of Health, Spain
- Directorate General for Assessment and Promotion of Research and the EU’s European Regional Development Fund
- Carlos III Institute of Health, Madrid, Spain
Zitieren
APA
Mora-Ortiz, M., Yubero-Serrano, E. M., Priego-Capote, F., Gutierrez-Mariscal, F. M., Alcala-Diaz, J. F., Torres-Peña, J. D., Arenas de-Larriva, A. P., Delgado-Lista, J., Perez-Martinez, P., Roche, H. M., & López-Miranda, J. (2024). Dietary Lipid Quantity and Quality Modulate the Postprandial Metabolomic Profile in Patients with Metabolic Syndrome. Nutrients. https://doi.org/10.3390/nu16244267
Vancouver
Mora-Ortiz M, Yubero-Serrano EM, Priego-Capote F, Gutierrez-Mariscal FM, Alcala-Diaz JF, Torres-Peña JD, et al. Dietary Lipid Quantity and Quality Modulate the Postprandial Metabolomic Profile in Patients with Metabolic Syndrome. Nutrients. 2024. doi:10.3390/nu16244267
BibTeX
@article{MoraOrtiz2024,
author = {Mora-Ortiz, Marina and Yubero-Serrano, Elena M and Priego-Capote, Feliciano and Gutierrez-Mariscal, Francisco M and Alcala-Diaz, Juan F and Torres-Peña, José D and Arenas de-Larriva, Antonio P and Delgado-Lista, Javier and Perez-Martinez, Pablo and Roche, Helen M and López-Miranda, José},
title = {Dietary Lipid Quantity and Quality Modulate the Postprandial Metabolomic Profile in Patients with Metabolic Syndrome},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16244267}
}
EUVIMED